Glut-1 was overexpressed in 67% (52/77) of non-BRCA mutation-related DCIS cases, with concomitant HIF-1α overexpression in 29% (22/77) of the cases (p = 0.022). The gene discussed is SLC2A1; the disease is ductal breast carcinoma in situ.